• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Domain, Elite Consulting to create, invest in life science companies in China

Domain, Elite Consulting to create, invest in life science companies in China

March 14, 2013
CenterWatch Staff

Domain Associates, a U.S. venture capital firm investing in breakthrough life sciences technologies, and Elite Consulting, consultants and financial advisors to the Chinese pharmaceutical and medical device industry, have formed a partnership to bring the most advanced healthcare products and technologies to China. 

The partnership, called Domain Elite, will establish new companies and joint ventures in China that will provide Western companies the financing, regulatory, medical and marketing support and infrastructure needed to bring their breakthrough products to China. Target technologies will be mainly focused in the areas of pharmaceuticals, diagnostics and medical devices. The partnership is exclusive and is envisioned to be the source of multiple emerging businesses in China over the course of several years.

"The Chinese healthcare system has a great and significant need for best-in-class, innovative therapies and medical products," said Brian Halak, PhD, partner at Domain Associates.  "We see Domain Elite as the first partnership of its kind to create new companies by leveraging the resources of both China and the U.S.  These companies will bring the most effective new drugs and novel technologies to fulfill unmet medical needs and improve healthcare in China. In the process, Domain will create its own investment opportunities in the rapidly expanding Chinese market."

Micah Zimmerman, partner at Elite Consulting, said, "From patients to doctors to the government, health is of major importance to everyone in China. Our analysis of the needs of the Chinese healthcare market led us to develop Domain Elite as a bridge between overseas technology companies and Chinese doctors and patients. Everyone benefits when patients can access the most advanced technologies to improve health."

The partnership brings together Elite Consulting's in-depth knowledge of the Chinese healthcare landscape with Domain's capital and deep networks, both within its portfolio and throughout the industry. Domain has provided seed financing to Domain Elite for the initial search and evaluation process and will contribute more significant capital for each new technology introduced to China.

"With more than three decades of experiences, connections and accomplishments in life sciences investing, Domain Associates understands how to found and execute industry leading investment solutions to launch and build successful companies that meet healthcare needs," said Zimmerman. "Domain's investment in Eddingpharm, a Chinese pharmaceuticals marketing company, and involvement in The Foundry, the premier U.S. medical device company incubator, illustrate Domain's innovation not only in addressing healthcare needs but also in establishing important collaborations that facilitate company creation for the development and marketing of cutting-edge technologies."

Halak added, "With an exclusive focus on healthcare and more than 16 years of experience in China, Beijing-based Elite Consulting brings incomparable local expertise and international dependability to developing new medical technologies and products for the Chinese market. We believe Domain Elite will create multiple successful companies that will translate cutting-edge medical technologies into impactful, best-in-class products for Chinese healthcare."

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing